Multibagger Update: This micro-cap pharma stock locked at 5 per cent upper circuit on securing multiple contracts!

Armaan Madhani
/ Categories: Trending, Multibaggers
Multibagger Update: This micro-cap pharma stock locked at 5 per cent upper circuit on securing multiple contracts!

Over the last 1 year and year to date, the stock has gained 165.19 per cent and 17.96 per cent, respectively. 

Shares of Fredun Pharmaceuticals are on a phenomenal roll. A solid price volume break out was witnessed in the counter today. The scrip has locked at 5 per cent upper circuit during early market hours to record an intra-day high of Rs 1,280.05 per share on BSE today.   

Over the last 1 year and year to date, the stock has gained 165.19 per cent and 17.96 per cent, respectively.    

Fredun Pharmaceuticals has signed two large contracts for Pharma and DC Granules. The company received a one-year contract worth Rs 65 crore from a Southeast Asian country for pharma exports. This contract is part of a much larger multiple-year contract and will be continued upon successful execution post first year.   

The company further signed a contract for specialized DC granules for various therapeutic end uses. The annual contract is worth Rs 25 crore and has the potential to go up to Rs 40 crore from second year onwards. These DC Granules will be exported as well as supplied to local companies across India.

Revenues from both contracts would commence from Q4FY23.

To quote, Fredun Medhora, Managing Director of Fredun Pharmaceuticals from a filing with the exchange, “ These contract wins are an important step in taking Fredun Pharmaceuticals to the next level. This reflects our capabilities that can be leveraged to further fuel growth for the company.”    

Fredun Pharmaceuticals Limited is engaged in the manufacturing of various pharmaceutical formulations for pharma companies in India and across Africa, South-East Asia and CIS countries and Latin America. It is also in the business of healthcare and aims to be a holistic healthcare provider.  

It primarily offers various generic pharma products across various therapeutic segments such as anti-bacterial, anti-malarial, anti-fungal, cardiovascular, nephrology, dietary supplements, etc.  

Watch out for this trending micro-cap pharma stock in the coming sessions!  

Rate this article:
3.5

1 comments on article "Multibagger Update: This micro-cap pharma stock locked at 5 per cent upper circuit on securing multiple contracts!"

Avatar image

S D BOSE

Good Ideas for Investments are being shared.

Leave a comment

This form collects your name, email, IP address and content so that we can keep track of the comments placed on the website. For more info check our Privacy Policy and Terms Of Use where you will get more info on where, how and why we store your data.
Add comment

DSIJ MINDSHARE

Mkt Commentary31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Knowledge

General27-Jan, 2023

All About Fiscal Policy

All About Fiscal Policy

The United States government directs fiscal policy with the goal of maintaining a healthy economy.

General27-Jan, 2023

Explained: Monetary Policy in India

Explained: Monetary Policy in India

Monetary policy is the activities governed by the central bank that aim to influence the management of the...

General20-Jan, 2023

Cost of Capital Explained!

Cost of Capital Explained!

A business expands by making investments that are expected to increase revenue and profits. It obtains the...
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION